Fascinating topic, akin to me wondering if one day we will also be able to engineer or set parameters for not just when we die but how- peacefully in our sleep, doing what we love, making sure we don't linger in pain, unable to communicate. A truly "advance directive."
The $1.2 quadrillion TAM is the number that will get quoted everywhere and its worth pressure-testing because it determines wether longevity is the greatest investment opportunity of the century or the greatest mislabelling of consumer surplus as addressable revenue.
ARK's methodology values quality-adjusted life years at $100K each. Thats a valid way to calculate the total economic value of longer healthier lives. But TAM in the venture capital sense means capturable revenue, and you cant capture consumer surplus as revenue unless you can charge people $100K per additional healthy year and have them pay it. Most people would pay significantly less than that, which means the investable market is a fraction of the headline number. The question is what fraction and the answer depends entirely on the cost curve.
This is where the AI convergence you describe becomes the most important variable in the entire thesis. If AI-engineered proteins achieve 50x improvments in cellular reprogramming factors as you report, and if autonomous drug discovery platforms like Lila Sciences compress the R&D timeline from decades to years, the cost of longevity interventions follows the solar panel trajectory: expensive at inception, rapidly declining through technological learning curves, eventually cheap enough for mass adoption. In that scenario the TAM genuinley approaches something extraordinary because the addressable population expands from billionaires to the entire middle class within 15-20 years.
The alternative trajectory is the luxury goods curve. Interventions stay expensive because the R&D costs are high, the regulatory pathway is slow, and the companies are incentivised to maintain premium pricing because their initial customer base can afford it. In that scenario longevity becomes a permanent advantage for the wealthy rather than a universal human advancement and the investable market caps out at maybe $50-100B annualy. Still enormous. Not $1.2 quadrillion.
The Retro Biosciences $1B raise and the NewLimit $280M are both priced for the solar panel trajectory. If theyre right and the cost curve bends the way it did for genomic sequencing, which went from $3 billion per genome to under $200 in twenty years, then the companies entering clinical trials now are positioned at the start of the steepest value creation curve in medical history. If the cost curve follows the pharmaceutical trajectory instead, where drugs stay expensive behind patent walls for 20 years, the returns are still good but the transformative TAM doesnt materialise.
The bowhead whale observation from medical school is the most effective framing in the piece by the way. 200-year lifespans already exist in nature. The question isnt wether radical healthspan extension is biologicaly possible. Its wether we can engineer the mechanism and price it for mass adoption within a single generation.
Warren Buffett bought Buffalo News. At first, recoverable paper pulp was a valuable commodity. Over time it became worthless and worse required costly disposal.
We hold Life dear in ethical terms, and assign value to each year it is extended.
But in economic terms, Life is only net-productive in the middle. It is a costly investment at the start, and a net consumer at the end.
Peter wrote: "I watched a documentary on the topic of “long-lived sea life” and learned that bowhead whales can live for 200 years, and the Greenland shark has an impressive lifespan of 400 to 500 years. I remember thinking, if they can live that long, why can’t we? My answer? “It’s either a hardware or a software problem, and we’re eventually going to be able to fix that.”"
----
Possibly this is due to the effective suspension of gravity in water? Gravity puts a large amount of strain on every organism.
Might living in a low to no-gravity environment off of Earth increase lifespan also? Let's get the experiment started!
The epigenetic reprogramming section is the most substantive treatment of partial reprogramming I have seen in a public newsletter. The distinction between full reprogramming and partial approaches that avoid teratoma risk is an important nuance that often gets lost in longevity coverage.
Peter wrote: "Today I’m releasing the updated 2026 edition of my Longevity Metatrend Report, and a lot has changed since the first edition. I believe access to information like this is crucial, so I've decided to make this report available at no cost."
----
Thanks for this. So very UN-Substack like!
There is too much greed on Substack and the price of subscriptions is beyond the reach of many regular people. Most Substack authors seem to want $80 to $100 or more per year to read their musings. That may sound fine for a single subscription but multiply that by 10 or more and you are into serious money.
When Substacks are paywalled to only paying customers, diversity of opinion is lost and what has been set-up is no different than an echo chamber of thought, which grows stale quickly with the same relatively small subset of people making the same repetitious comments over and over and over.
Peter wrote: "The Greatest Business Opportunity of this Decade"
----
Suggest everyone tune into the CNN series now running called "Kara Swisher wants to live forever". She's up to episode 4. She covers all the longevity treatments that the well-to-do are currently paying for and using, in her trademark snarky style, which can get old after a bit but the info is enlightening and potentially useful.
While I am a big fan and totally in agreement with Longevity and Abundance in the future (and even today). The problem is presentation. Always looking at it as profit center is wrong eyed. The most successful ventures always look at the product as the ends not a means to. develop wealth. Wealth comes as a by-product. This is the problem that create the AI technology PR issue with the regular people. They do not see Longevity and Abundance as anything more than a way the super rich will become more wealthy and more in control. There is no real, tangible results for them. Frame of reference ios very important. The technical super class do not get this. They are too focused on more, more, more. Operation 25. You of all people should be the leader of this position.
I am in the Longevity Olympics - only complete dedication will give one the max level each can reach. I believe this is too much a $$ discussion - all that will enhance life span should be easily accessible - not a supplement money grab … the hardest part will be having people make the right choices because we all know what one needs to do for healthy long life and yet 99.9% of all humans don’t follow these easy steps…
$1.2 Quadrillion? That’s like 10x the entire world economy currently. I’m curious exactly HOW increasing the lifespans of already retired people by 10 years, will generate more revenue than the entire world’s economy by an order of magnitude?
Love your focus on health! Curious what you see as the future importantance of simply eating well and exercising. As of today Pepsi is America's #1 supplier of health education in schools, with programs that push junk food on kids.
I still believe it's vital that we reclaim control over health education, so we can raise new generations who care about their health from an early age
Fascinating topic, akin to me wondering if one day we will also be able to engineer or set parameters for not just when we die but how- peacefully in our sleep, doing what we love, making sure we don't linger in pain, unable to communicate. A truly "advance directive."
The $1.2 quadrillion TAM is the number that will get quoted everywhere and its worth pressure-testing because it determines wether longevity is the greatest investment opportunity of the century or the greatest mislabelling of consumer surplus as addressable revenue.
ARK's methodology values quality-adjusted life years at $100K each. Thats a valid way to calculate the total economic value of longer healthier lives. But TAM in the venture capital sense means capturable revenue, and you cant capture consumer surplus as revenue unless you can charge people $100K per additional healthy year and have them pay it. Most people would pay significantly less than that, which means the investable market is a fraction of the headline number. The question is what fraction and the answer depends entirely on the cost curve.
This is where the AI convergence you describe becomes the most important variable in the entire thesis. If AI-engineered proteins achieve 50x improvments in cellular reprogramming factors as you report, and if autonomous drug discovery platforms like Lila Sciences compress the R&D timeline from decades to years, the cost of longevity interventions follows the solar panel trajectory: expensive at inception, rapidly declining through technological learning curves, eventually cheap enough for mass adoption. In that scenario the TAM genuinley approaches something extraordinary because the addressable population expands from billionaires to the entire middle class within 15-20 years.
The alternative trajectory is the luxury goods curve. Interventions stay expensive because the R&D costs are high, the regulatory pathway is slow, and the companies are incentivised to maintain premium pricing because their initial customer base can afford it. In that scenario longevity becomes a permanent advantage for the wealthy rather than a universal human advancement and the investable market caps out at maybe $50-100B annualy. Still enormous. Not $1.2 quadrillion.
The Retro Biosciences $1B raise and the NewLimit $280M are both priced for the solar panel trajectory. If theyre right and the cost curve bends the way it did for genomic sequencing, which went from $3 billion per genome to under $200 in twenty years, then the companies entering clinical trials now are positioned at the start of the steepest value creation curve in medical history. If the cost curve follows the pharmaceutical trajectory instead, where drugs stay expensive behind patent walls for 20 years, the returns are still good but the transformative TAM doesnt materialise.
The bowhead whale observation from medical school is the most effective framing in the piece by the way. 200-year lifespans already exist in nature. The question isnt wether radical healthspan extension is biologicaly possible. Its wether we can engineer the mechanism and price it for mass adoption within a single generation.
Context matters, Assets can become liabilities.
Warren Buffett bought Buffalo News. At first, recoverable paper pulp was a valuable commodity. Over time it became worthless and worse required costly disposal.
We hold Life dear in ethical terms, and assign value to each year it is extended.
But in economic terms, Life is only net-productive in the middle. It is a costly investment at the start, and a net consumer at the end.
Peter wrote: "I watched a documentary on the topic of “long-lived sea life” and learned that bowhead whales can live for 200 years, and the Greenland shark has an impressive lifespan of 400 to 500 years. I remember thinking, if they can live that long, why can’t we? My answer? “It’s either a hardware or a software problem, and we’re eventually going to be able to fix that.”"
----
Possibly this is due to the effective suspension of gravity in water? Gravity puts a large amount of strain on every organism.
Might living in a low to no-gravity environment off of Earth increase lifespan also? Let's get the experiment started!
I'm the musical version of Peter! 🔊
Listen to my tracks for a future positive, human progress oriented vibe!
The epigenetic reprogramming section is the most substantive treatment of partial reprogramming I have seen in a public newsletter. The distinction between full reprogramming and partial approaches that avoid teratoma risk is an important nuance that often gets lost in longevity coverage.
At what point are we just making up numbers? I'm not sure anyone can even fathom what a quadrillion is.
While the data and outlook is tantalizing, I’m not sure you gave us action steps to start and invest in.
Peter wrote: "Today I’m releasing the updated 2026 edition of my Longevity Metatrend Report, and a lot has changed since the first edition. I believe access to information like this is crucial, so I've decided to make this report available at no cost."
----
Thanks for this. So very UN-Substack like!
There is too much greed on Substack and the price of subscriptions is beyond the reach of many regular people. Most Substack authors seem to want $80 to $100 or more per year to read their musings. That may sound fine for a single subscription but multiply that by 10 or more and you are into serious money.
When Substacks are paywalled to only paying customers, diversity of opinion is lost and what has been set-up is no different than an echo chamber of thought, which grows stale quickly with the same relatively small subset of people making the same repetitious comments over and over and over.
"Information wants to be free"
-- Stewart brand
Peter wrote: "The Greatest Business Opportunity of this Decade"
----
Suggest everyone tune into the CNN series now running called "Kara Swisher wants to live forever". She's up to episode 4. She covers all the longevity treatments that the well-to-do are currently paying for and using, in her trademark snarky style, which can get old after a bit but the info is enlightening and potentially useful.
As always, Peter is the fountain of information for the fountain of youth. Important work on so many levels. The man is a treasure.
While I am a big fan and totally in agreement with Longevity and Abundance in the future (and even today). The problem is presentation. Always looking at it as profit center is wrong eyed. The most successful ventures always look at the product as the ends not a means to. develop wealth. Wealth comes as a by-product. This is the problem that create the AI technology PR issue with the regular people. They do not see Longevity and Abundance as anything more than a way the super rich will become more wealthy and more in control. There is no real, tangible results for them. Frame of reference ios very important. The technical super class do not get this. They are too focused on more, more, more. Operation 25. You of all people should be the leader of this position.
I weekly share big updates about health in my longevity noodles
I am in the Longevity Olympics - only complete dedication will give one the max level each can reach. I believe this is too much a $$ discussion - all that will enhance life span should be easily accessible - not a supplement money grab … the hardest part will be having people make the right choices because we all know what one needs to do for healthy long life and yet 99.9% of all humans don’t follow these easy steps…
$1.2 Quadrillion? That’s like 10x the entire world economy currently. I’m curious exactly HOW increasing the lifespans of already retired people by 10 years, will generate more revenue than the entire world’s economy by an order of magnitude?
I'd like to upgrade to a paid subscription, but your website offers no way to cancel.
Love your focus on health! Curious what you see as the future importantance of simply eating well and exercising. As of today Pepsi is America's #1 supplier of health education in schools, with programs that push junk food on kids.
I still believe it's vital that we reclaim control over health education, so we can raise new generations who care about their health from an early age